Latest filing published 05 Jun 2023 for TCR2 THERAPEUTICS INC..
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
MPM SunStates Fund, L.P.: trading record in brief
Filings by MPM SunStates Fund, L.P. span 2 companies, the busiest being TCR2 Therapeutics Inc. and Oncorus, Inc. Over a trading history stretching from 19 February 2019 to 1 June 2023, the count stands at 7 filings.
Purchases make up the whole of the open-market record (2 purchases, €11.6M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 5 June 2023 came the latest disclosure, a transaction in TCR2 Therapeutics Inc. The most recent open-market purchase was published on 8 October 2020, 2,222 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to MPM SunStates Fund, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,158,964 shares0Common StockSEC:0001209191-23-034343:0
- ▲
Same trade as the filing by MPM BioVentures 2014, L.P., counted once
3M USD31SEC173,776 shares@ US$15.00100.0% of flowCommon StockSEC:0001209191-20-054326:2Canonical exit: 4 Jan 2021 (T+90) - 1,783,879 sharesCommon StockSEC:0001209191-20-054326:0
- 775,975 sharesCommon StockSEC:0001209191-20-054326:1
- 2,825,396 sharesCommon StockSEC:0001209191-19-012245:0
- 322,901 sharesCommon StockSEC:0001209191-19-012245:1
- ▲
Same trade as the filing by MPM BioVentures 2014, L.P., counted once
11M USD31SEC706,666 shares@ US$15.00100.0% of flowCommon StockSEC:0001209191-19-012245:2Canonical exit: 20 May 2019 (T+90)
7 of 5 declarations
